Oral complaints in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation

xlomafota13 shared this article with you from Inoreader Oral complaints in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation Via pubmed: "med oral patol oral... Med Oral Patol Oral Cir Bucal. 2021 Jun 24:24647. doi: 10.4317/medoral.24647. Online ahead of print. ABSTRACT BACKGROUND: Acute myeloid leukemia belongs to proliferative diseases of the hematopoietic system. It is currently the leading indication for allogeneic hematopoietic stem cell transplantation. This study was designed to determine the most common subjective oral mucosa complaints in patients with acute myeloid leukemia after allogeneic hematopoietic cell transplantation, in relation to the type of conditioning used. MATERIAL AND METHODS: Eighty patients diagnosed with acute myeloid leukemia were assigned to two groups depending on the intensity of the conditioning regimen before transplantation: myeloablative and reduced-intensity chemotherapy. The oral symptoms were evaluated based on an authorial questionnaire designed for this analysis. The following oral mucosa subjective complaints were included: pain, paraesthesia, b urning mouth sensation, taste disorders, excessive salivation, halitosis, and dryness of the oral mucosa. RESULTS: The most commonly reported subjective oral complaint in the examined patients was xerostomia, which was found in 92% of patients during the second visit, followed by spontaneous pain in the mouth (55%), burning (36%), and dysgeusia (20%). It occurred significantly more frequently in patients who underwent myeloablative conditioning. Moreover, it was observed that the frequency of complaints increased considerably after the transplantation, reaching a peak intensity during the second week following the procedure. CONCLUSIONS: Oral complaints significantly decrease the patients' quality of life during the transplantation and may lead to premature termination of the treatment. As the number of transplantations in patients with acute myeloid leukemia increases, further investigations of oral complaints and symptoms induced by the disease itself and by the therap eutic approaches are required. PMID:34162819 | DOI:10.4317/medoral.24647 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.